\
&
Contact us
\
&
Contact us
Published on | 3 months ago
Programmes CybersecurityThe National Cybersecurity Coordination Centre (NCC-BE) has opened a call to assist Belgian beneficiaries, such as start-ups, scale-ups, SMEs and/or mid-caps, in the uptake or development of digital innovation
The call topic “Developing infrastructure or digital awareness tools using state-of-the-art technologies providing essential capabilities related to cybersecurity for SMEs” may encompass, but is not limited to, the following features:
More information on this call can be found on the Funding & Tenders Portal and on the website of the NCC-BE.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Research Infrastructures Digital, Industry & Space Agro-Food, Environment
The Central European Research Infrastructure Consortium (CERIC-ERIC) is calling for proposals for coordinated access to more than 60 instruments and support laboratories for research in all fields of materials, biomaterials and nanotechnology. A detailed description of the facilities available in CERIC can be found here. CERIC... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
